Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2020 Feb;130(2):437-441.
doi: 10.1002/lary.27956. Epub 2019 Apr 10.

Deep neuromuscular blockade for endolaryngeal procedures: A multicenter randomized study

Affiliations
Randomized Controlled Trial

Deep neuromuscular blockade for endolaryngeal procedures: A multicenter randomized study

Prok Laosuwan et al. Laryngoscope. 2020 Feb.

Abstract

Objectives/hypothesis: The aim of the present study was to compare the surgical condition between deep neuromuscular blockade (NMB) and moderate NMB.

Study design: Multicenter, randomized, parallel intervention trial.

Methods: One hundred two patients underwent microscopic endolaryngeal surgery at four university hospitals. The patients were randomized into moderate NMB (train-of-four 1-2) (M group) or deep NMB (post-tetanic count 1-2) (D group) with moderate or high doses of rocuronium, respectively. Surgical rating conditions (SRCs) were evaluated during the surgery. Sugammadex was given to the M group at 2 mg/kg and the D group at 4 mg/kg. Perioperative clinical signs and conditions were recorded until discharge from the postanesthesia care unit.

Results: Clinically acceptable SRC was observed in 49 patients (100%) in the D group and 43 patients (89.6%) in the M group (P = .027). The frequency of notable vocal fold movement in the M group was significantly higher than the D group (70.8% vs. 32.7%). The patients in the M group required more additional doses of rocuronium (47.9%) than the D group (20.4%) to maintain full relaxation (P = .005). The median time (interquartile range) from administration of sugammadex to train-of-four ratio 0.9 in the D group was shorter than the M group (120 [109-180 minutes] vs. 180 minutes [120-240 minutes], P = .034).

Conclusions: Deep NMB with high doses of rocuronium combined with 4 mg/kg of sugammadex for reversal during endolaryngeal surgery provided better SRC and anesthetic conditions than moderate NMB of rocuronium with 2 mg/kg of sugammadex.

Level of evidence: 1b Laryngoscope, 130:437-441, 2020.

Keywords: Rocuronium; endolaryngeal; neuromuscular blockade; reversal agent; sugammadex.

PubMed Disclaimer

References

BIBLIOGRAPHY

    1. Martini CH, Boon M, Bevers RF, Aarts LP, Dahan A. Evaluation of surgical conditions during laparoscopic surgery in patients with moderate vs deep neuromuscular block. Br J Anaesth 2014;112:498-505.
    1. Puura AI, Rorarius MG, Manninen P, Hoppu S, Baer GA. The costs of intense neuromuscular block for anesthesia during endolaryngeal procedures due to waiting time. Anesth Analg 1999;88:1335-1339.
    1. van den Broek L, Proost JH, Wierda JM. Early and late reversibility of rocuronium bromide. Eur J Anaesthesiol Suppl 1994;9:128-132.
    1. Hemmerling TM, Donati F. Neuromuscular blockade at the larynx, the diaphragm and the corrugator supercilii muscle: a review. Can J Anaesth 2003;50:779-794.
    1. Sorgenfrei IF, Norrild K, Larsen PB, et al. Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study. Anesthesiology 2006;104:667-674.

Publication types

LinkOut - more resources